Virulence, drug sensitivity and transmission success in the rodent malaria, Plasmodium chabaudi

Proceedings of the Royal Society B: Biological Sciences

Volumn 279, Issue 1747, 2012, Pages 4677-4685

  Schneider, Petra ^a   Bell, Andrew S ^b   Sim, Derek G ^b   O'Donnell, Aidan J ^a   Blanford, Simon ^b   Paaijmans, Krijn P ^b   Read, Andrew F ^b,c   Reece, Sarah E ^a  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

^b PENNSYLVANIA STATE UNIVERSITY   (United States)

^c NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

Competition; Drug resistance; Fitness; Genetically diverse infection; Transmission; Virulence evolution

Indexed keywords

COMPETITION (ECOLOGY); DISEASE TRANSMISSION; DRUG; DRUG RESISTANCE; GENOTYPE; HOST-PARASITE INTERACTION; MALARIA; PARASITIC DISEASE; PHENOTYPE; RODENT; SENSITIVITY ANALYSIS; VIRULENCE;

EID: 84867529976     PISSN: 09628452     EISSN: 14712954     Source Type: Journal    
DOI: 10.1098/rspb.2012.1792     Document Type: Article

References (52)

1. Lynch, P. A., Grimm, U. & Read, A. F. 2008 How will public and animal health interventions drive life-history evolution in parasitic nematodes? Parasitology 135, 1599-1611. (doi:10.1017/S0031182008000309)
2. Palumbi, S. R. 2001 Humans as the world's greatest evolutionary force. Science 293, 1786-1790. (doi:10.1126/science.293.5536.1786)
3. Foster, K. R. 2005 Biomedicine. Hamiltonian medicine: why the social lives of pathogens matter. Science 308, 1269-1270. (doi:10.1126/science.1108158)
4. Ewald, P. W. 1994 The evolution of infectious disease. Oxford, UK: Oxford University Press.
5. Frank, S. A. 1996 Models of parasite virulence. Q. Rev. Biol. 71, 37-78. (doi:10.1086/419267)
6. Williams, P. D. 2010 Darwinian interventions: taming pathogens through evolutionary ecology. Trends Parasitol. 26, 83-92. (doi:10.1016/j.pt.2009.11.009)
7. Babayan, S. A., Read, A. F., Lawrence, R. A., Bain, O. & Allen, J. E. 2010 Filarial parasites develop faster and reproduce earlier in response to host immune effectors that determine filarial life expectancy. PLoS Biol. 8, e1000525. (doi:10.1371/journal.pbio.1000525)
8. Reece, S. E., Ali, E., Schneider, P. & Babiker, H. A. 2010 Stress, drugs and the evolution of reproductive restraint in malaria parasites. Proc. R. Soc. B 277, 3123-3129. (doi:10.1098/rspb.2010.0564)
9. Teuscher, F., Gatton, M. L., Chen, N., Peters, J., Kyle, D. E. & Cheng, Q. 2010 Artemisinin-induced dormancy in Plasmodium falciparum: duration, recovery rates, and implications in treatment failure. J. Infect. Dis. 202, 1362-1368. (doi:10.1086/656476)
10. Veiga, M. I., Ferreira, P. E., Schmidt, B. A., Ribacke, U., Björkman, A., Tichopad, A. & Gil, J. P. 2010 Antimalarial exposure delays Plasmodium falciparum intra-erythrocytic cycle and drives drug transporter genes expression. PLoS ONE 5, e12408. (doi:10.1371/journal.pone.0012408)
11. Witkowski, B., Lelièvre, J., Barragán, M. J., Laurent, V., Su, X. Z., Berry, A. & Benoit-Vical, F. 2010 Increased tolerance to artemisinin in Plasmodium falciparum is mediated by a quiescence mechanism. Antimicrob. Agents Chemother. 54, 1872-1877. (doi:10.1128/AAC. 01636-09)
12. Schneider, P., Chan, B. H., Reece, S. E. & Read, A. F. 2008 Does the drug sensitivity of malaria parasites depend on their virulence? Malaria J. 7, 257. (doi:10. 1186/1475-2875-7-257)
13. Dhar, N. & McKinney, J. D. 2007 Microbial phenotypic heterogeneity and antibiotic tolerance. Curr. Opin. Microbiol. 10, 30-38. (doi:10.1016/j.mib.2006.12.007)
14. Wiuff, C., Zappala, R. M., Regoes, R. R., Garner, K. N., Baquero, F. & Levin, B. R. 2005 Phenotypic tolerance: antibiotic enrichment of noninherited resistance in bacterial populations. Antimicrob. Agents Chemother. 49, 1483-1494. (doi:10.1128/AAC.49.4.1483-1494.2005)
15. Leignel, V. & Cabaret, J. 2001 Massive use of chemotherapy influences life traits of parasitic nematodes in domestic ruminants. Funct. Ecol. 15, 569-574. (doi:10. 1046/j.0269-8463.2001.00567.x)
16. Mah, T.-F. C. & O'Toole, G. A. 2001 Mechanisms of biofilm resistance to antimicrobial agents. Trends Microbiol. 9, 34-39. (doi:10.1016/S0966-842X(00)01913-2)
17. Stewart, P. S. & Costerton, J. W. 2001 Antibiotic resistance of bacteria in biofilms. Lancet 358, 135-138. (doi:10.1016/S0140-6736(01)05321-1)
18. Nakazawa, S., Kanbara, H. & Aikawa, M. 1998 Recrudescence of Plasmodium falciparum in culture: unaffectedness and frequency of dormant parasites. J. Exp. Clin. Med. 23, 99-100.
19. Costerton, J. W., Stewart, P. S. & Greenberg, E. P. 1999 Bacterial biofilms: a common cause of persistent infections. Science 284, 1318-1322. (doi:10.1126/science.284.5418.1318)
20. Mideo, N., Barclay, V. C., Chan, B. H. K., Savill, N. J., Read, A. F. & Day, T. 2008 Understanding and predicting strain-specific patterns of pathogenesis in the rodent malaria Plasmodium chabaudi. Am. Nat. 172, e214-e238. (doi:10.1086/591684)
21. Schmid-Hempel, P. 2009 Immune defence, parasite evasion strategies and their relevance for 'macroscopic phenomena' such as virulence. Phil. Trans. R. Soc. B 364, 85-98. (doi:10.1098/rstb.2008.0157)
22. Kumar, N. & Zheng, H. 1990 Stage-specific gametocytocidal effect in vitro of the antimalaria drug qinghaosu on Plasmodium falciparum. Parasitol. Res. 76, 214-218. (doi:10.1007/BF00930817)
23. WHO. 2011 Global plan for artemisinin resistance containment (GPARC). See http://www.who.int/malaria/publications/atoz/9789241500838/en/index.html.
24. Jacobs, R. L. 1964 Role of p-aminobenzoic acid in Plasmodium berghei infection in the mouse. Exp. Parasitol. 15, 213-225. (doi:10.1016/0014-4894(64)90017-7)
25. Beale, G. H., Carter, R. &Walliker, D. 1978 Genetics. In Rodent malaria (ed. R. P. W. Killick-Kendrick), pp. 213-245. London, UK: Academic Press.
26. Mackinnon, M. J. & Read, A. F. 1999 Selection for high and low virulence in the malaria parasite Plasmodium chabaudi. Proc. R. Soc. Lond. B 266, 741-748. (doi:10.1098/rspb.1999.0699)
27. Mackinnon, M. J., Gaffney, D. J. & Read, A. F. 2002 Virulence in rodent malaria: host genotype by parasite genotype interactions. Infect. Genet. Evol. 1, 287-296. (doi:10.1016/S1567-1348(02)00039-4)
28. Ebert, D. 1998 Experimental evolution of parasites. Science 282, 1432-1436. (doi:10.1126/science.282.5393.1432)
29. Drew, D. R. & Reece, S. E. 2007 Development of reverse-transcription PCR techniques to analyse the density and sex ratio of gametocytes in genetically diverse Plasmodium chabaudi infections. Mol. Biochem. Parasitol. 156, 199-209. (doi:10.1016/j.molbiopara.2007.08.004)
30. Wargo, A. R., Randle, N., Chan, B. H. K., Thompson, J., Read, A. F. & Babiker, H. A. 2006 Plasmodium chabaudi: Reverse transcription PCR for the detection and quantification of transmission stage malaria parasites. Exp. Parasitol. 112, 13-20. (doi:10.1016/j.exppara.2005.08.013)
31. Hunt, P. et al. 2010 Experimental evolution, genetic analysis and genome re-sequencing reveal the mutation conferring artemisinin resistance in an isogenic lineage of malaria parasites. BMC Genomics 11, 499. (doi:10. 1186/1471-2164-11-499)
32. Dondorp, A. M., Yeung, S., White, L., Nguon, C., Day, N. P., Socheat, D. & von Seidlein, L. 2010 Artemisinin resistance: current status and scenarios for containment. Nat. Rev. Microbiol. 8, 272-280. (doi:10.1038/nrmicro2331)
33. Ferrer-Rodriguez, I., Perez-Rosado, J., Gervais, G. W., Peters, W., Robinson, B. R. & Serrano, A. E. 2004 Plasmodium yoelii identification and partial characterization of an mdr1 gene in an artemisinin-resistance line. J. Parasitol. 90, 152-160. (doi:10.1645/GE-3225)
34. Rodrigues, L. A., Henriques, G., Borges, S. T., Hunt, P., Sanchez, C. P., Martinelli, A. & Cravo, P. 2010 Experimental evolution of resistance to artemisinin combination therapy results in amplification of the mdr1 gene in a rodent malaria parasite. PLoS ONE 5, e11593. (doi:10.1371/journal.pone.0011593)
35. Xiao, S. H., Yao, J. M., Utzinger, J., Cai, Y., Chollet, J. & Tanner, M. 2004 Selection and reversal of Plasmodium berghei resistance in the mouse model following repeated high doses of artemether. Ann. Trop. Med. Parasitol. 92, 215-219. (doi:10.1007/s00436-003-1029-9)
36. Hunt, P. et al. 2007 Gene encoding a deubiquitinating enzyme is mutated in artesunate-and chloroquineresistant rodent malaria parasites. Mol. Microbiol. 65, 27-40. (doi:10.1111/j.1365-2958.2007.05753.x)
37. Hadfield, J. D. 2010 MCMC Methods for multiresponse generalized linear mixed models: The MCMCglmm R package. J. Stat. Softw. 33, 1-22.
38. Schneider, P., Bousema, J. T., Gouagna, L. C., Otieno, S., Vegte-Bolmer, M.v.d., Omar, S. A. & Sauerwein, R. W. 2007 Submicroscopic Plasmodium falciparum gametocyte densities frequently result in mosquito infection. Am. J. Trop. Med. Hyg. 76, 470-474.
39. Mackinnon, M. J. & Read, A. F. 2004 Immunity promotes virulence evolution in a malaria model. PLoS Biol. 2, E230. (doi:10.1371/journal.pbio.0020230)
40. de Roode, J. C. et al. 2005 Virulence and competitive ability in genetically diverse malaria infections. Proc. Natl Acad. Sci. USA 102, 7624-7628. (doi:10.1073/pnas.0500078102)
41. Nakazawa, S., Kanbara, H. &Aikawa, M.1995 Plasmodium falciparum: recrudescence of parasites in culture. Exp. Parasitol. 81, 556-563. (doi:10.1006/expr.1995.1149)
42. Nakazawa, S., Maoka, T., Uemura, H., Ito, Y. & Kanbara, H. 2002 Malaria parasites giving rise to recrudescence in vitro. Antimicrob. Agents Chemother. 46, 958-965. (doi:10.1128/AAC.46.4.958-965.2002)
43. Teuscher, F., Chen, N., Kyle, D. E., Gatton, M. L. & Cheng, Q. 2011 Phenotypic changes in artemisinin resistant Plasmodium falciparum lines in vitro: evidence for decreased sensitivity to dormancy and growth inhibition. Antimicrob. Agents Chemother. 56, 428-431. (doi:10.1128/AAC.05456-11)
44. Tucker, M. S., Mutka, T., Sparks, K., Patel, J. & Kyle, D. E. 2011 Phenotypic and genotypic analysis of in vitro selected artemisinin-resistant progeny of Plasmodium falciparum. Antimicrob. Agents Chemother. 56, 302-314. (doi:10.1128/AAC.05540-11)
45. Stein, W. D., Sanchez, C. P. & Lanzer, M. 2009 Virulence and drug resistance in malaria parasites. Trends Parasitol. 25, 441-443. (doi:10.1016/j.pt.2009.07.003)
46. Barnes, K. I. et al. 2007 World Antimalarial Resistance Network (WARN) IV: Clinical pharmacology. Malaria J. 6, 122. (doi:10.1186/1475-2875-6-122)
47. White, N. J. 1998 Why is it that antimalarial drug treatments do not always work? Ann. Trop. Med. Parasitol. 92, 449-458. (doi:10.1080/00034989859429)
48. White, N. J. 1997 Assessment of the pharmacodynamic properties of antimalarial drugs in vivo. Antimicrob. Agents Chemother. 41, 1413-1422.
49. Bjorkman, A. & Bhattarai, A. 2005 Public health impact of drug resistant Plasmodium falciparum malaria. Acta Trop. 94, 163-169. (doi:10.1016/j.actatropica.2005.04.015)
50. Trape, J. F. 2001 The public health impact of chloroquine resistance in Africa. Am. J. Trop. Med. Hyg. 64, S12-S17.
51. Mideo, N. & Reece, S. E. 2012 Plasticity in parasite phenotypes: evolutionary and ecological implications for disease. Future Microbiol. 7, 17-24. (doi:10.2217/fmb.11.134)
52. Walliker, D., Hunt, P. & Babiker, H. 2005 Fitness of drugresistant malaria parasites. Acta Trop. 94, 251-259. (doi:10.1016/j.actatropica.2005.04.005)